Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
TRex Bio Inc.
TRXB · SEC Filings
website
60
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory disease...
Price
13.59
Market Cap
374.78 M
Float
7.46 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about TRXB
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
TRex Bio Inc.
TRXB · SEC Filings
7.46 M
Float
13.59
Price
374.78 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
News
TYPE
HEADLINE
FILED AT
Prospectus
TYPE
HEADLINE
FILED AT
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 9, 2026
8-A12B
Form 8-A12B - Registration of securities [Section 12(b)]
Oct 6, 2026
S-1/A
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Oct 5, 2026
S-1
Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 18, 2026
DRS/A
Form DRS/A - Draft Registration Statement: [Amend]
Aug 21, 2026
DRS/A
Form DRS/A - Draft Registration Statement: [Amend]
Jul 31, 2026
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G
PFIZER INC (Filed by)
Oct 16, 2026
SCHEDULE 13D
ELI LILLY & Co (Filed by)
Oct 16, 2026
SCHEDULE 13D
SV Biotech Crossover Opportunities Fund LP (Filed by)
Oct 16, 2026
4
Alexandria Venture Investments, LLC (Reporting)
Oct 15, 2026
SCHEDULE 13G
Johnson & Johnson Innovation - JJDC, Inc. (Filed by)
Oct 15, 2026
4
MARCUS JOEL S (Reporting)
Oct 13, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Oct 9, 2026
